Skip to main content

Table 3 Follow-up

From: The impact of the use of bioresorbable vascular scaffolds and drug-coated balloons in coronary bifurcation lesions

Follow-upn = 40
Angiographic follow-up13 (32.5%)
Angiographic follow-up indication 
Stable angina8 (9%)
Unstable angina3 (7.5%)
STEMI1 (2.5%)
NSTEMI1 (2.5%)
% diameter stenosis of MV in case of angio follow-up2.9 ± 3.4%
% diameter stenosis of SB11 ± 29.49%
Average duration from index procedure to the last follow-up (days)444 ± 303
Binary restenosis MV0%
Binary restenosis SB1 (2.5%)
MV MLD3.2 ± 0.47 mm
SB MLD1.784 ± 0.6 mm
MV TLR0%
SB TLR0%
Aspirin at follow-up40 (100%)
P2Y12 inhibitors at follow-up25 (62.5%)
Death0%
CV death0%
Non CV death0%
TV MI1 (2.5%)
TV MI managementPOBA
TLR0%
TVR1(2.5%)
Date of TVR10-4-2014
TLR or TVR managementPOBA
TL thrombosis0%